Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1006937 | 0.81 | CYP3A4 (0.57) | CYP3A4MAPTNPSR1ALDH1A1HSD17B10 | |
| SCHEMBL1008759 | 0.79 | ALDH1A1 (0.55) | CYP3A4MAPTNPSR1ALDH1A1LMNA | |
| Acetone SCHEMBL11800599 | 0.74 | CYP3A4 (0.76) | CYP3A4MAPTNPSR1ALDH1A1TSHR | |
| SCHEMBL464613 | 0.73 | CYP3A4 (0.67) | CYP3A4MAPTNPSR1ALDH1A1HSD17B10 | |
| SCHEMBL21238177 | 0.72 | NPSR1 (0.54) | CYP3A4MAPTNPSR1ALDH1A1HSD17B10 | |
| SCHEMBL12580005 | 0.72 | CYP3A4 (0.64) | CYP3A4MAPTNPSR1ALDH1A1CYP2D6 | |
| SCHEMBL12580004 | 0.72 | CYP3A4 (0.64) | CYP3A4MAPTNPSR1ALDH1A1CYP2D6 | |
| SCHEMBL28662 | 0.72 | CYP3A4 (1.00) | CYP3A4MAPTNPSR1ALDH1A1CYP2D6 | |
| SCHEMBL24495885 | 0.71 | CYP3A4 (0.52) | CYP3A4MAPTNPSR1ALDH1A1CYP2D6 | |
| SCHEMBL7160182 | 0.70 | CYP3A4 (0.61) | CYP3A4MAPTNPSR1ALDH1A1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2277945-B1 | CROSS-LINKABLE POLYMER COMPOSITION, AND MOLDED PRODUCT OF THE COMPOSITION | NIPPON KASEI CHEM (JP) | 2014-08-27 | — | — | EP | disclosed |
| US-8445600-B2 | Crosslinking agent, and crosslinking polymer composition and molded product formed of the same | NIPPON KASEI CHEMICAL COMPANY LIMITED (JP) | 2013-05-21 | — | — | US | disclosed |
| US-20110105687-A1 | CROSSLINKING AGENT, AND CROSSLINKING POLYMER COMPOSITION AND MOLDED PRODUCT FORMED OF THE SAME | SHINRYO CORPORATION (JP) | 2011-05-05 | — | — | US | disclosed |
| EP-2277945-A1 | CROSS-LINKING AGENT, CROSS-LINKABLE POLYMER COMPOSITION, AND MOLDED PRODUCT OF THE COMPOSITION | Nippon Kasei Chemical Company Limited (JP) | 2011-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105687-A1 | CROSSLINKING AGENT, AND CROSSLINKING POLYMER COMPOSITION AND MOLDED PRODUCT FORMED OF THE SAME | TST, H1-0, H1-3 | CYP3A4 753/4885MAPT 1403/4885NPSR1 4410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.